Lazcluze 80 mg, Filmtabletten
7680697510018
CH-69751
L01EB09
07.16.1.
1 / 2
google
Details
- Product number
- 6975101
- CPT
- -
- Packaging group
- 56
- Unit
- Tablette(n)
- Composition
- lazertinibum 80 mg ut lazertinibi mesilas monohydricus, silica hydrophobica colloidalis, cellulosum microcristallinum, mannitolum, carmellosum natricum conexum corresp. natrium max. 0.8 mg, magnesii stearas, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, E 171, glyceroli monocaprylocapras, E 172 (flavum), poly(alcohol vinylicus), pro compresso obducto.
Articles (1)
Lazcluze 80 mg, Filmtabletten
Filmtabletten
56
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
80.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 5988.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2025
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 69751
- Drug name
- Lazcluze, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EB09
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 07/02/2025
- Authorization expiration date
- 06/02/2030
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LAZCLUZE cpr pellic 80 mg 56 pce
- Description (DE)
- LAZCLUZE Filmtabl 80 mg 56 Stk
- Market launch
- 27/06/2025
- Narcotic (BTM)
- No